Results from the AHA late-breaking trials on cell-based therapies.
作者信息
Taylor Jennifer
出版信息
Eur Heart J. 2013 Apr;34(14):1016-7.
PMID:23682394
Abstract
摘要
相似文献
1
Results from the AHA late-breaking trials on cell-based therapies.
Eur Heart J. 2013 Apr;34(14):1016-7.
2
Bone marrow-derived cell therapy after myocardial infarction--reply.
JAMA. 2013 Apr 10;309(14):1459-60. doi: 10.1001/jama.2013.2604.
3
Mixed results for bone marrow–derived cell therapy for ischemic heart disease.
JAMA. 2012 Dec 12;308(22):2405-6. doi: 10.1001/jama.2012.64751.
4
Bone marrow-derived cell therapy after myocardial infarction.
JAMA. 2013 Apr 10;309(14):1459. doi: 10.1001/jama.2013.2601.
5
[Stem cell therapy in ischemic heart disease].
Ugeskr Laeger. 2006 Mar 13;168(11):1111-4.
6
Bone marrow cell therapy after myocardial infarction. What should we select?
Eur Heart J. 2009 Jun;30(11):1310-2. doi: 10.1093/eurheartj/ehp181. Epub 2009 May 7.
7
Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Am Heart J. 2011 Mar;161(3):487-93. doi: 10.1016/j.ahj.2010.11.024.
8
[Stem cells after myocardial infarction].
Herz. 2006 Apr;31(2):127-36; quiz 142-3. doi: 10.1007/s00059-006-2794-x.
9
Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation.
Eur Heart J. 2010 Mar;31(6):691-702. doi: 10.1093/eurheartj/ehp536. Epub 2009 Dec 17.
10
[Stem cell transfer in myocardial infarction].
Dtsch Med Wochenschr. 2006 Apr 21;131(16):881-3. doi: 10.1055/s-2006-939862.
Zotero 插件